I love this example. So timely for a recent conve
Post# of 148301
Earlier this week, I was trying to explain CYDY's current situation to a friend. I said "it's like if the Beverly Hillbillies found a billion barrels of oil on their property and, instead of calling Exxon, selling out for a fortune, and heading to CA to live the good life, they decided to extract the oil themselves with a shovel, pickaxe, and bucket."
Although their effort might be well-intentioned and sincere, they would be undermanned and underfunded for the task at hand. And, sure, if everything went perfectly and they learned along the way, they may end up making more money in the long run. But, in the meantime, they also run the risk of one wrong spark and the whole thing blowing up in their faces.
This is how I am starting to feel about CYDY management's apparent strategy to try and develop a potential multi-indication, multi-billion dollar drug $400,000 at a time with $0.30 raises with warrant coverage while trading on the OTC.
Quote:
Things often shift during negotiations, and, for example, if you were in negotiations to buy a piece of property for $100,000 but then the seller learned the property had oil under it, you may not have enough to offer the seller for what the new information brings as to the value of the property, even though $100,000 was initially a fair price. Hopefully that is what happened here with Leronlimab.